NSE: CCL | BSE: 519600

Mid-range Performer

Download real time

857.85 4.20 (0.49%)

63.40% Gain from 52W Low

82,393 NSE+BSE Volume

NSE 03 Oct, 2025 3:31 PM (IST)

11,454.7

Market Cap

Market Runner Up

0.5

Beta 1Year

Very Low volatility

CCL Products India Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for CCL, BSE:519600 CCL Products India Ltd.

CCL Products India Ltd.

01 Nov 2022

857.85

0.49%

Result Update:CCL Products

Buy: CCL Products India Ltd.

Target

Axis Direct

We expect CCLP's Sales/EBITDA/PAT to grow at 31%/27%/26% CAGR over FY22-25E and maintaina high conviction BUY rating on the stock with a unchanged TP of Rs 600/share as we roll over our estimates to 23x Sept-24 EPS.

CCL Products India Ltd. has gained 50.75% in the last 6 Months

CCL Products India Ltd.

26 Aug 2022

857.85

0.49%

CCL Products (India) Ltd

Hold: CCL Products India Ltd.

Target

CD Equisearch

CCL Products India Ltd. is trading below its 30 day SMA of 892.6

CCL Products India Ltd.

08 Aug 2022

857.85

0.49%

CCL Products (India): Q1FY23 Result Review

Buy: CCL Products India Ltd.

Target

IDBI Capital

CCL Products India Ltd. is trading below its 30 day SMA of 892.6

CCL Products India Ltd.

30 May 2022

857.85

0.49%

Result Update:CCL Products

Buy: CCL Products India Ltd.

Target

Axis Direct

CCL Products is one of our high conviction BUY with a revised TP of Rs 560/share (Rs 585/share earlier), as we continue to value it at a target P/E multiple of 23x its FY24E EPS.

CCL Products India Ltd. is trading below its 30 day SMA of 892.6

CCL Products India Ltd.

21 Jan 2022

857.85

0.49%

Result Update:CCL Products

CCL Products India Ltd.

Axis Direct

CCL Products is one of our high conviction BUY. Following our estimate revision, the new TP is Rs 585 (Rs. 530 earlier), as we continue to value it at target P/E multiple to 23x its FY24E EPS.

CCL Products India Ltd. has gained 50.75% in the last 6 Months

CCL Products India Ltd.

08 Nov 2021

857.85

0.49%

Pick of the Week:8 Nov 2021

Buy: CCL Products India Ltd.

Target

Axis Direct

We recommend BUY with TP of Rs. 430/share.

CCL Products India Ltd. has gained 50.75% in the last 6 Months

CCL Products India Ltd.

29 Oct 2021

857.85

0.49%

CCL Products (India): Q2FY22 Result Review

Buy: CCL Products India Ltd.

Recommendation Target

IDBI Capital

We raise our FY22/FY23 sales forecast given rise in coffee prices in recent months but maintain our profitability (on per kg basis) estimates. We introduce FY24 forecast in this report. We now value the stock at a PER of 18x FY24E (earlier 22x FY24E) EPS and derive a target price of Rs459 (previous Rs446) and upgrade the stock to a BUY. Key Highlights and Investment Rationale Robust top-line growth: Net sales grew by 4.5% YoY to Rs3.4 bn in Q2FY22 mainly led by higher coffee prices. CCL's EBITDA margin improved 38bps YoY at 24.4% despite sharp rise in freight rates. The freight rates continue to remain high which could pose...

Number of FII/FPI investors decreased from 181 to 149 in Jun 2025 qtr

CCL Products India Ltd.

22 Oct 2021

857.85

0.49%

CCL Products (India) Ltd

Hold: CCL Products India Ltd.

Recommendation Target

CD Equisearch

Partially helped by robust growth in domestic business, CCLP posted 12.8% growth in revenues in Q1 at Rs 326.12 crs compared to Rs 289.20 crs in the same quarter a year ago., but slightly lower than Rs 331.58 crs reported in Q4. Part of the fall in revenues in Q1 compared to Q4 is attributed to higher off take of small packs of freeze dried coffee in Q4. Despite rise in green coffee prices and rise in freight costs, OPM expanded by 40 bps in Q1 all thanks to improved product mix. Helped by nearly 15%...

Number of MF schemes decreased from 58 to 25 in Jun 2025 qtr

CCL Products India Ltd.

30 Jul 2021

857.85

0.49%

CCL Products (India): Q1FY22 Result Review

Hold: CCL Products India Ltd.

Target

IDBI Capital

CCL Product's Q1FY22 result was a mixed bag. While top-line was higher than our estimate by 9%, its EBITDA was 5% below our forecast. Net sales increased by 13% YoY to Rs3,261 mn mainly on higher offtake. EBIDTA grew 14.5% YoY to Rs720 mn. However, sharp increase in tax expense (+35% YoY to Rs99 mn) restricted its net profit...